Literature DB >> 28049386

Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements.

Hana Dobšíček Trefná1, Hans Crezee2, Manfred Schmidt3, Dietmar Marder4, Ulf Lamprecht5, Michael Ehmann6, Josefin Hartmann3, Jacek Nadobny7, Johanna Gellermann5,8, Netteke van Holthe9, Pirus Ghadjar7, Nicoletta Lomax4, Sultan Abdel-Rahman10, Christoph Bert3,11, Akke Bakker2, Mark D Hurwitz12, Chris J Diederich13, Paul R Stauffer12, Gerard C van Rhoon9.   

Abstract

Quality assurance guidelines are essential to provide uniform execution of clinical trials and treatment in the application of hyperthermia. This document provides definitions for a good hyperthermia treatment and identifies the clinical conditions where a certain hyperthermia system can or cannot adequately heat the tumour volume. It also provides brief description of the characteristics and performance of the current electromagnetic (radiative and capacitive), ultrasound and infra-red heating techniques. This information helps to select the appropriate heating technique for the specific tumour location and size, and appropriate settings of the water bolus and thermometry. Finally, requirements of staff training and documentation are provided. The guidelines in this document focus on the clinical application and are complemented with a second, more technical quality assurance document providing instructions and procedure to determine essential parameters that describe heating properties of the applicator for superficial hyperthermia. Both sets of guidelines were developed by the ESHO Technical Committee with participation of senior STM members and members of the Atzelsberg Circle.

Entities:  

Keywords:  Quality assurance; clinical; hyperthermia; superficial

Year:  2017        PMID: 28049386     DOI: 10.1080/02656736.2016.1277791

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  17 in total

Review 1.  Ultrasound Hyperthermia Technology for Radiosensitization.

Authors:  Lifei Zhu; Michael B Altman; Andrei Laszlo; William Straube; Imran Zoberi; Dennis E Hallahan; Hong Chen
Journal:  Ultrasound Med Biol       Date:  2019-02-14       Impact factor: 2.998

2.  Breath-hold MR-HIFU hyperthermia: phantom and in vivo feasibility.

Authors:  Chenchen Bing; Bingbing Cheng; Robert M Staruch; Joris Nofiele; Michelle Wodzak Staruch; Debra Szczepanski; Alan Farrow-Gillespie; Adeline Yang; Theodore W Laetsch; Rajiv Chopra
Journal:  Int J Hyperthermia       Date:  2019       Impact factor: 3.914

Review 3.  Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.

Authors:  Keon Mahmoudi; Alexandros Bouras; Dominique Bozec; Robert Ivkov; Constantinos Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2018-02-06       Impact factor: 3.914

4.  Feasibility and safety assessment of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated mild hyperthermia in pelvic targets evaluated using an in vivo porcine model.

Authors:  Lifei Zhu; Ari Partanen; Michael R Talcott; H Michael Gach; Suellen C Greco; Lauren E Henke; Jessika A Contreras; Imran Zoberi; Dennis E Hallahan; Hong Chen; Michael B Altman
Journal:  Int J Hyperthermia       Date:  2019       Impact factor: 3.914

5.  Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.

Authors:  Oliver Stoetzer; Dorit Di Gioia; Rolf Dieter Issels; Sultan Abdel-Rahman; Ulrich Mansmann; Lars Hartwin Lindner; Oleg Gluz; Rachel Würstlein; Michael Braun; Moritz Hamann; Franz Edler von Koch; Nadia Harbeck; Christoph Salat
Journal:  Breast Care (Basel)       Date:  2020-05-12       Impact factor: 2.860

Review 6.  Quality assurance guidelines for superficial hyperthermia clinical trials : II. Technical requirements for heating devices.

Authors:  Hana Dobšíček Trefná; Johannes Crezee; Manfred Schmidt; Dietmar Marder; Ulf Lamprecht; Michael Ehmann; Jacek Nadobny; Josefin Hartmann; Nicolleta Lomax; Sultan Abdel-Rahman; Sergio Curto; Akke Bakker; Mark D Hurwitz; Chris J Diederich; Paul R Stauffer; Gerard C Van Rhoon
Journal:  Strahlenther Onkol       Date:  2017-03-01       Impact factor: 3.621

Review 7.  Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.

Authors:  Niloy R Datta; H Petra Kok; Hans Crezee; Udo S Gaipl; Stephan Bodis
Journal:  Front Oncol       Date:  2020-06-12       Impact factor: 6.244

8.  Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy.

Authors:  Michael Hader; Deniz Pinar Savcigil; Andreas Rosin; Philipp Ponfick; Stephan Gekle; Martin Wadepohl; Sander Bekeschus; Rainer Fietkau; Benjamin Frey; Eberhard Schlücker; Udo S Gaipl
Journal:  Cancers (Basel)       Date:  2020-04-27       Impact factor: 6.639

9.  Modelling Curved Contact Flexible Microstrip Applicators for Patient-Specific Superficial Hyperthermia Treatment Planning.

Authors:  H Petra Kok; Jort Groen; Akke Bakker; Johannes Crezee
Journal:  Cancers (Basel)       Date:  2020-03-11       Impact factor: 6.639

10.  Design, Implementation, Evaluation and Application of a 32-Channel Radio Frequency Signal Generator for Thermal Magnetic Resonance Based Anti-Cancer Treatment.

Authors:  Haopeng Han; Thomas Wilhelm Eigentler; Shuailin Wang; Egor Kretov; Lukas Winter; Werner Hoffmann; Eckhard Grass; Thoralf Niendorf
Journal:  Cancers (Basel)       Date:  2020-06-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.